Abstract

Efficacy and safety of risankizumab in patients with moderate-to-severe plaque psoriasis: a real-life retrospective study

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call